Loading…
Loading grant details…
| Funder | European Commission |
|---|---|
| Recipient Organization | Technische Universitaet Dresden |
| Country | Germany |
| Start Date | Sep 01, 2022 |
| End Date | Aug 31, 2027 |
| Duration | 1,825 days |
| Number of Grantees | 17 |
| Roles | Participant; Third Party; Associated Partner; Coordinator |
| Data Source | European Commission |
| Grant ID | 101057434 |
Invasive mechanical ventilation (MV) is one of the most important and life-saving therapies in the intensive care unit (ICU). In most severe cases, when MV alone is insufficient, extracorporeal lung support (ELS) is initiated.
However, MV is recognised as potentially harmful, because inappropriate MV settings in ICU patients are associated with organ damage, contributing to disease burden. Studies revealed that MV is often not properly provided despite clear evidence and guidelines.
Furthermore, treatment decisions by the healthcare providers, especially regarding MV and ELS, often remain incomprehensible to the patients and their relatives, since flow of information from caregivers to patients is challenged by a number of factors, including limited time and resources, communication problems as well as patients? capacity to comprehend and memorise information.
The project proposed herein aims at clinically validating and extending our IntelliLung Artificial Intelligence Decision Support System (AI-DSS) designed to optimise MV and ELS settings to improve the care of ICU patients, alongside caregiver-patient communication.
Thereby, best practice evidence-based MV and ELS within safer therapy corridors for longer periods, faster weaning from MV, and improved survival could be achieved - even in non-experienced hands.
Additionally, this project will improve the information flow from caregivers to patients and relatives in the ICU setting.
Therefore, we will develop a digital solution that allows automatic generation of an extensive plain-language information package for patients and their relatives, communicating highly individualised information on diseases and knowledge-based disease-management strategies, thus facilitating high-quality current and subsequent care through health literacy empowerment and patient-centredness.
We will perform a retrospective and prospective multi-centre study to validate our IntelliLung AI-DSS and the patient information software.
Fundacio Institut D'Investigació I Innovació Parc Tauli; Demcon Life Sciences & Healtheindhoven B.V.; Centralny Szpital Kliniczny Ministerstwa Spraw Wewnetrznych I Administracji W Warszawie; Better Care Sl; European Society of Anaesthesiology and Intensive Care Aisbl; Fundacion Para la Investigacion Biomedica Del Hospital Universitario la Princesa; Insel Gruppe Ag; Servicio Madrileno de Salud; Demcon Macawi Respiratory Systems Bv; Irccs Ospedale Policlinico San Martino; Institut Mihajlo Pupin; The Cleveland Clinic Foundation; Universita Degli Studi Di Genova; Was Hab' Ich? Gemeinnutzige Gmbh; Fundacion Publica Andaluza Progreso Y Salud M.P.; Institut Fur Angewandte Informatik (Infai) Ev; Technische Universitaet Dresden
Complete our application form to express your interest and we'll guide you through the process.
Apply for This Grant